Changes to the Code
H.R. 1492 · To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 1320f–1 Selection of negotiation-eligible drugs as selected drugs
1 change the bill asks for here, 1 carried out
- Carried out:
Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended by striking
7 years
and inserting11 years
.
§ 1320f–1(e)(1)In general(A)–(B)
Start of § 1320f–1 to (e)(1)(A) unchanged ·
(i) that is approved under section 355(c) of title 21 and is marketed pursuant to such approval;
(ii) for which, as of the selected drug publication date with respect to such initial price applicability year, at least [struck: 7][inserted: 11] years will have elapsed since the date of such approval; and
(iii) that is not the listed drug for any drug that is approved and marketed under section 355(j) of such title.
(B) Biological products A biological product—
Rest of § 1320f–1 unchanged ·